نتایج جستجو برای: tenofovir disproxil fumarate

تعداد نتایج: 10210  

Journal: :Journal of Clinical and Experimental Hepatology 2013

Journal: :Science 2016
S van Velzen G E Anderson N C Stone M Fraser T Wevers B D Metzger P G Jonker A J van der Horst T D Staley A J Mendez J C A Miller-Jones S T Hodgkin H C Campbell R P Fender

The tidal disruption of a star by a supermassive black hole leads to a short-lived thermal flare. Despite extensive searches, radio follow-up observations of known thermal stellar tidal disruption flares (TDFs) have not yet produced a conclusive detection. We present a detection of variable radio emission from a thermal TDF, which we interpret as originating from a newly launched jet. The multi...

2017
David A Wohl Rima Kulkarni Will Garner Kirsten White Danielle Porter

State University, Columbus, Ohio, Capital Medical Associates, Washington DC, DC, The Dr James J Rahal Jr. Division of Infectious Disease, NewYork-Presbyterian Queens, Flushing, New York, La Playa Medical Group, San Diego, California, AIDS Healthcare Foundation, Los Angeles, California, APEX Research, Denver, Colorado, Atlanta Infectious Disease Group PC, Atlanta, Georgia, Gilead Sciences, Foste...

Journal: :The Journal of infectious diseases 2015
Rachel A Bender Ignacio Tara Perti Amalia S Magaret Sharanya Rajagopal Claire E Stevens Meei-Li Huang Stacy Selke Christine Johnston Jeanne Marrazzo Anna Wald

BACKGROUND Tenofovir is a potent anti-human immunodeficiency virus (HIV) agent that decreased risk of herpes simplex virus type 2 (HSV-2) acquisition in HIV pre-exposure prophylaxis trials. Whether tenofovir has utility in established HSV-2 disease is unclear. METHODS We randomized immunocompetent women with symptomatic HSV-2 infection to oral tenofovir disoproxil fumarate (TDF)/placebo vagin...

Journal: :The Journal of infectious diseases 2004
Michael D Miller Nicolas Margot Biao Lu Lijie Zhong Shan-Shan Chen Andrew Cheng Michael Wulfsohn

Results from 2 placebo-controlled intensification trials of tenofovir disoproxil fumarate (DF) in treatment-experienced human immunodeficiency type 1 (HIV-1)-infected patients (n=332) were integrated to determine the effects of resistance at baseline on HIV-1 RNA response. In these trials, there was a high prevalence of HIV-1 resistance mutations, with 94% of patients having nucleoside-associat...

Journal: :Topics in antiviral medicine 2015
Kenneth E Sherman

All patients with HIV infection should be screened for hepatitis B virus (HBV) infection. Preventive HBV vaccination is less effective in HIV-infected patients than in those without HIV infection. Emtricitabine, lamivudine, and tenofovir disoproxil fumarate (tenofovir) each have activity against HIV and HBV. In HBV/HIV-coinfected patients, if HBV or HIV treatment is needed, it should be initiat...

2017
Ruijun Chen Rebecca Scherzer Priscilla Y. Hsue Vasantha Jotwani Michelle M. Estrella Michael A. Horberg Carl Grunfeld Michael G. Shlipak

BACKGROUND The antiretroviral medication, tenofovir disoproxil fumarate (TDF), is used by most human immunodeficiency virus-infected persons in the United States despite higher risks of chronic kidney disease. Although chronic kidney disease is a strong risk factor for heart failure (HF), the association of TDF with incident HF is unclear. METHODS AND RESULTS We identified 21 435 human immuno...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید